Searching for the Genetic Source
A new study from the Medical College of Georgia has established a link between fat and chemical changes in DNA. This may explain the increased risk of cardiovascular disease and diabetes among obese individuals.
Making the Affordable Care Act ... Affordable
Health and Human Services (HHS) Secretary Kathleen Sebelius has announced the aid of grants to help states implement Health Insurance Exchanges, a key provision of the Affordable Care Act.
HIV Patients May Have Yet Another Strike Against Them
Individuals with HIV may be up to three times more likely to suffer stroke than the general population, according to a recent study.
Lung Disease Leads to Death from Other Causes
Patients who are undergoing long-term oxygen therapy to treat chronic obstructive pulmonary disease (COPD) have an increased risk of death from other non-respiratory health complications.
The New Gateway Drug
The illegal use of HGH (human growth hormone) by male weightlifters is a prevalent issue in the United States, according to a study that appears in the American Journal on Addictions .
Kidneys on the Move
Johns Hopkins researchers have found that kidneys shipped on ice for transplant are just as safe and effective as kidneys that come from donors in the same hospital where the transplant operation takes place.
What We've Got Here Is Failure to Communicate
A recent article in the Journal of Clinical Epidemiology says that health care systems are failing to apply evidence from studies to inform their decision-making.
Malaria, You've Been Busted!
Australian scientists have achieved the most detailed and vivid images of the malaria parasite invading red blood cells ever to be captured, offering a glimpse into how the mosquito-borne illness works.
A Small Conversation about a Big Decision
New research shows that surrogate decision-makers who had not discussed life support measures with their critically ill family members have more trouble making the final judgement.
A new study suggests there isn't enough evidence to recommend the widespread use of cholesterol-lowering stain drugs for patients who don't have a history of cardiovascular disease.